Search research articles
Contact Us
Filters
Showing results (11-20 of 38) with videos related to
Page
of 4
Sort By:
Metabolism: Clinical and Experimental
|
May 20, 2017
siRNA-mediated inhibition of SREBP cleavage-activating protein reduces dyslipidemia in spontaneously dysmetabolic rhesus monkeys
Beth Ann Murphy, Marija Tadin-Strapps, Kristian Jensen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 15, 2021
Randomized Study of Rivaroxaban vs Placebo on Disease Progression and Symptoms Resolution in High-Risk Adults With Mild Coronavirus Disease 2019
Jintanat Ananworanich, Robin Mogg, Michael W Dunne, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 12, 2009
Tolerability of two sequential electroporation treatments using MedPulser DNA delivery system (DDS) in healthy adults
Mark Wallace, Barbara Evans, Sandra Woods, et al.
Pharmacogenomics
|
June 29, 2019
The pharmacogenetics of OATP1B1 variants and their impact on the pharmacokinetics and efficacy of elbasvir/grazoprevir
Zifang Guo, Luzelena Caro, Michael N Robertson, et al.
Clinical and Translational Science
|
August 31, 2021
Safety, tolerability, and pharmacokinetics of single- and multiple-dose administration of islatravir (MK-8591) in adults without HIV
Randolph P Matthews, Wendy Ankrom, Evan Friedman, et al.
The Lancet. Global Health
|
April 18, 2021
How COVID-19 has fundamentally changed clinical research in global health
Jay J H Park, Robin Mogg, Gerald E Smith, et al.
Journal of Sleep Research
|
August 13, 2014
Efavirenz modulation of sleep spindles and sleep spectral profile
Arthur A Simen, Junshui Ma, Vladimir Svetnik, et al.
European Clinical Respiratory Journal
|
November 12, 2015
Kinetics of TH2 biomarkers in sputum of asthmatics following inhaled allergen
Rob G J A Zuiker, Marcella K Ruddy, Nicoletta Morelli, et al.
Trials
|
December 11, 2020
Nebulised surfactant for the treatment of severe COVID-19 in adults (COV-Surf): A structured summary of a study protocol for a randomized controlled trial
Ahilanandan Dushianthan, Howard Clark, Jens Madsen, et al.
The Lancet. Oncology
|
February 4, 2018
Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study
Giuseppe Giaccone, Chul Kim, Jillian Thompson, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 38) with videos related to
Sort By:
Page
of 4
Metabolism: Clinical and Experimental
|
May 20, 2017
siRNA-mediated inhibition of SREBP cleavage-activating protein reduces dyslipidemia in spontaneously dysmetabolic rhesus monkeys
Beth Ann Murphy, Marija Tadin-Strapps, Kristian Jensen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 15, 2021
Randomized Study of Rivaroxaban vs Placebo on Disease Progression and Symptoms Resolution in High-Risk Adults With Mild Coronavirus Disease 2019
Jintanat Ananworanich, Robin Mogg, Michael W Dunne, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 12, 2009
Tolerability of two sequential electroporation treatments using MedPulser DNA delivery system (DDS) in healthy adults
Mark Wallace, Barbara Evans, Sandra Woods, et al.
Pharmacogenomics
|
June 29, 2019
The pharmacogenetics of OATP1B1 variants and their impact on the pharmacokinetics and efficacy of elbasvir/grazoprevir
Zifang Guo, Luzelena Caro, Michael N Robertson, et al.
Clinical and Translational Science
|
August 31, 2021
Safety, tolerability, and pharmacokinetics of single- and multiple-dose administration of islatravir (MK-8591) in adults without HIV
Randolph P Matthews, Wendy Ankrom, Evan Friedman, et al.
The Lancet. Global Health
|
April 18, 2021
How COVID-19 has fundamentally changed clinical research in global health
Jay J H Park, Robin Mogg, Gerald E Smith, et al.
Journal of Sleep Research
|
August 13, 2014
Efavirenz modulation of sleep spindles and sleep spectral profile
Arthur A Simen, Junshui Ma, Vladimir Svetnik, et al.
European Clinical Respiratory Journal
|
November 12, 2015
Kinetics of TH2 biomarkers in sputum of asthmatics following inhaled allergen
Rob G J A Zuiker, Marcella K Ruddy, Nicoletta Morelli, et al.
Trials
|
December 11, 2020
Nebulised surfactant for the treatment of severe COVID-19 in adults (COV-Surf): A structured summary of a study protocol for a randomized controlled trial
Ahilanandan Dushianthan, Howard Clark, Jens Madsen, et al.
The Lancet. Oncology
|
February 4, 2018
Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study
Giuseppe Giaccone, Chul Kim, Jillian Thompson, et al.
Page
of 4